GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dannex Ayrton Starwin PLC (XGHA:DASPHARMA) » Definitions » Net Income From Continuing Operations

Dannex Ayrton Starwin (XGHA:DASPHARMA) Net Income From Continuing Operations : GHS0.00 Mil (TTM As of . 20)


View and export this data going back to 2020. Start your Free Trial

What is Dannex Ayrton Starwin Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Dannex Ayrton Starwin's net income from continuing operations for the six months ended in . 20 was GHS0.00 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in . 20 was GHS0.00 Mil.

Dannex Ayrton Starwin Net Income From Continuing Operations Historical Data

The historical data trend for Dannex Ayrton Starwin's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dannex Ayrton Starwin Net Income From Continuing Operations Chart

Dannex Ayrton Starwin Annual Data
Trend
Net Income From Continuing Operations

Dannex Ayrton Starwin Semi-Annual Data
Net Income From Continuing Operations

Dannex Ayrton Starwin Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Net Income From Continuing Operations for the trailing twelve months (TTM) ended in . 20 was GHS0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dannex Ayrton Starwin (XGHA:DASPHARMA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dannex Ayrton Starwin PLC (XGHA:DASPHARMA) » Definitions » Net Income From Continuing Operations
Comparable Companies
Traded in Other Exchanges
N/A
Address
No. 5 Dadeban Road, Ring Road North, North Industrial Area, Accra, GHA
Website
https://www.dasplcgh.com
Dannex Ayrton Starwin PLC is a pharmaceutical company. The company offers a product range that includes tablets, capsules, liquids syrups and suspensions, powders, ointments, and chemicals. It also manufactures and distributes Vitamin C.

Dannex Ayrton Starwin (XGHA:DASPHARMA) Headlines

No Headlines